ArticleBioinformatics (Oxford, England)2025
An innovative peptide toxicity prediction model based on multi-scale convolutional neural network and residual connection.
Article in Bioinformatics (Oxford, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- ToxiCompass: an evidence-tracked benchmark for short-peptide toxicity screening and confidence-aware assay prioritization.Briefings in bioinformatics · 2026Article
- ToxMamba: a novel method for toxic peptide prediction based on the fusion of pretrained embeddings and multi-scale state space models.Briefings in bioinformatics · 2026Article
- Review
- INBAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
- Recent advances in multimodal foundation model-enabled peptide screening and optimization for smart biomaterials and functional tissue engineering.Frontiers in bioengineering and biotechnology · 2026Review
- TPT: a compact CNN-transformer encoder for efficient microbial small protein modeling.Frontiers in microbiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
motivationPeptide toxicity is a critical concern in the development of peptide-based therapeutics, as toxic peptides can lead to severe side effects, including organ damage, immune reactions, and cytotoxicity. Predicting peptide toxicity accurately is essential to ensure the safety and efficacy of these drugs.
resultsIn this study, we propose a novel model, ToxMSRC, to predict peptide toxicity using a combination of the continuous bag of words (CBOW) method from word2vec, synthetic minority over-sampling technique (SMOTE), multi-scale convolutional neural networks (CNN), and bidirectional long short-term memory (BiLSTM). This approach addresses the challenge of data imbalance by augmenting positive samples and improves feature extraction through multi-scale convolution. Furthermore, the model incorporates a residual connection that helps prevent overfitting and enhances generalization ability, improving classification performance. The model is evaluated on benchmark and independent test sets, achieving BACC scores of 92.17% on independent test1 and 86.89% on independent test2, outperforming existing state-of-the-art models. Additionally, ToxMSRC provides valuable insights into the relationship between peptide toxicity and amino acid sequences, demonstrating its potential and practical value in peptide-based drug development. AVAILABILITY AND IMPLEMENTATION: The complete datasets, source code, and pre-trained models are made available at https://github.com/Renjingyi123/ToxMSRC and https://doi.org/10.5281/zenodo.15668530.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.